Last year brought economic growth and success for law firms, but 2021 was not only marked with good news. A slew of law firms were dragged into litigation by disgruntled ex-clients, with some paying out millions of dollars to resolve lawsuits accusing them of giving bad advice.
A group of banks that failed to prove steel giant Arrium falsified representations on loan drawdown notices ahead of its $2.8 billion collapse have been ordered to pay indemnity costs after a court found they rejected $10 million settlement offers three days into the trial.
General Motors has lost its bid to de-class a representative proceeding brought by former Holden dealers over its decision to retire the iconic brand, with a judge rejecting the car maker’s “speculative” argument that it would be prejudiced by further lawsuits after the class action was finalised.
An appeals court has dismissed an appeal in a professional negligence lawsuit by a New South Wales developer against HWL Ebsworth over a due diligence report that led to the purchase of a $25.5 million parcel of government land at risk of flooding.
General Motors is facing a lawsuit by a Holden car dealer who allegedly suffered up to $9.26 million in financial loss following the car maker’s decision to pull the iconic brand in Australia.
A judge has recused himself from hearing a dispute over the alleged infringement of the copyright for the disco classic ‘Love Is In the Air’ on the eve of a damages hearing.
Construction company Delcon Civil is facing a lawsuit by a subcontractor seeking over $3.4 million in damages for alleged breach of contract relating to work on the North East Link project.
Accounting giant Deloitte has lost its bid to throw out a former client’s lawsuit alleging negligence and fraud over a failed interposition under tax law that occurred more than 16 years ago.
Liberty Mutual Insurance does not have to indemnify dam operator Sunwater for its share of a $440 million settlement of the Queensland floods class action, the NSW Supreme Court has found.
A judge was “mistaken” to find that AFT Pharmaceuticals’ ads for its painkiller Maxigesic were misleading, with the Full Federal Court ruling there was an adequate scientific foundation for the ads’ claims that the drug provided faster, better pain relief than paracetamol and ibuprofen alone.